Development of pyridyl thiosemicarbazones as highly potent agents for the treatment of malaria after oral administration.
Saved in:
| Title: | Development of pyridyl thiosemicarbazones as highly potent agents for the treatment of malaria after oral administration. |
|---|---|
| Authors: | Parkinson CJ; School of Biomedical Sciences, Charles Sturt University, Orange, Australia., Birrell GW; Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia., Chavchich M; Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia., Mackenzie D; Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia., Haynes RK; Centre for Excellence in Pharmaceutical Discovery, North-West University, Potchefstroom, South Africa., de Kock C; Division of Pharmacology, University of Cape Town, Observatory, South Africa., Richardson DR; Molecular Pharmacology and Pathology Program, Department of Pathology and Bosch Institute, The University of Sydney, Sydney, Australia., Edstein MD; Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia. |
| Source: | The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Oct 01; Vol. 74 (10), pp. 2965-2973. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1460-2091 |
|---|---|
| DOI: | 10.1093/jac/dkz290 |
